Erasca (ERAS) Retained Earnings (2020 - 2026)
Erasca (ERAS) posted Retained Earnings of -$699000.0 for Q1 2026, down 211.31% on a QoQ basis from $628000.0 in Q4 2025, and up 99.91% year-over-year from -$349653.0 in Q1 2025.
Erasca (ERAS) Retained Earnings (2020 - 2026) Analysis & Trends
Erasca's Retained Earnings history runs 7 years deep, the most recent figure standing at -$699000.0 for Q1 2026.
- Quarterly Retained Earnings rose 99.91% year-over-year to -$699000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$699000.0 (up 99.91% YoY) and the FY2025 annual result came in at $628000.0, up 100.08% from the prior year.
- Retained Earnings was -$699000.0 for Q1 2026 at Erasca, down from $628000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $1.8 million in Q3 2024 and bottomed at -$832.5 million in Q2 2025.
- A 5-year average of -$365.3 million and a median of -$345.7 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 100.32% — and 2025, when it sank 380185.71%.
- Erasca's Retained Earnings stood at -$481.0 million in 2022, then declined by 26.0% to -$606.0 million in 2023, then retreated by 26.67% to -$767.7 million in 2024, then jumped by 100.08% to $628000.0 in 2025, then tumbled by 211.31% to -$699000.0 in 2026.
- Business Quant data shows ERAS's Retained Earnings at -$699000.0 in Q1 2026, $628000.0 in Q4 2025, and $649000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -699,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -699,000.00 |
| Dec 31, 2025 | 628,000.00 |
| Sep 30, 2025 | 649,000.00 |
| Jun 30, 2025 | -832.51 Mn |
| Mar 31, 2025 | -798.60 Mn |
| Dec 31, 2024 | -767.66 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | -704.23 Mn |
| Mar 31, 2024 | -210,000.00 |
| Dec 31, 2023 | -606.01 Mn |
| Sep 30, 2023 | -576.30 Mn |
| Jun 30, 2023 | -793,000.00 |
| Mar 31, 2023 | -514.20 Mn |
| Dec 31, 2022 | -480.97 Mn |
| Sep 30, 2022 | -345.70 Mn |
| Jun 30, 2022 | -310.23 Mn |
| Mar 31, 2022 | -274.60 Mn |
| Dec 31, 2021 | -238.17 Mn |
| Sep 30, 2021 | -207.70 Mn |
| Jun 30, 2021 | -161.60 Mn |